nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—melanoma	0.229	1	CbGaD
Atazanavir—ABCC1—Vemurafenib—melanoma	0.196	0.312	CbGbCtD
Atazanavir—ABCC1—Dactinomycin—melanoma	0.13	0.207	CbGbCtD
Atazanavir—SLCO1B3—Docetaxel—melanoma	0.0971	0.155	CbGbCtD
Atazanavir—ABCC1—Docetaxel—melanoma	0.0671	0.107	CbGbCtD
Atazanavir—CYP3A4—Temozolomide—melanoma	0.0516	0.0824	CbGbCtD
Atazanavir—ABCB1—Dactinomycin—melanoma	0.0314	0.05	CbGbCtD
Atazanavir—CYP3A4—Vemurafenib—melanoma	0.0283	0.0451	CbGbCtD
Atazanavir—ABCB1—Docetaxel—melanoma	0.0162	0.0258	CbGbCtD
Atazanavir—CYP3A4—Docetaxel—melanoma	0.00971	0.0155	CbGbCtD
Atazanavir—Lopinavir—ABCB1—melanoma	0.000435	0.318	CrCbGaD
Atazanavir—Ritonavir—ABCB1—melanoma	0.000366	0.267	CrCbGaD
Atazanavir—Hyperglycaemia—Temozolomide—melanoma	0.000354	0.00278	CcSEcCtD
Atazanavir—Stomatitis—Carmustine—melanoma	0.000353	0.00278	CcSEcCtD
Atazanavir—Urinary tract infection—Carmustine—melanoma	0.000352	0.00277	CcSEcCtD
Atazanavir—Depression—Temozolomide—melanoma	0.000349	0.00274	CcSEcCtD
Atazanavir—Hepatitis—Dactinomycin—melanoma	0.000348	0.00273	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000347	0.00273	CcSEcCtD
Atazanavir—Body temperature increased—Vemurafenib—melanoma	0.000345	0.00271	CcSEcCtD
Atazanavir—Neuropathy peripheral—Temozolomide—melanoma	0.000343	0.0027	CcSEcCtD
Atazanavir—Stomatitis—Temozolomide—melanoma	0.000341	0.00268	CcSEcCtD
Atazanavir—Urinary tract infection—Temozolomide—melanoma	0.00034	0.00267	CcSEcCtD
Atazanavir—Hepatobiliary disease—Temozolomide—melanoma	0.000331	0.0026	CcSEcCtD
Atazanavir—Alopecia—Bleomycin—melanoma	0.000329	0.00259	CcSEcCtD
Atazanavir—Erythema multiforme—Dactinomycin—melanoma	0.000329	0.00258	CcSEcCtD
Atazanavir—Hypoaesthesia—Carmustine—melanoma	0.000324	0.00254	CcSEcCtD
Atazanavir—Hallucination—Carmustine—melanoma	0.000324	0.00254	CcSEcCtD
Atazanavir—Hypersensitivity—Vemurafenib—melanoma	0.000322	0.00253	CcSEcCtD
Atazanavir—Oedema peripheral—Carmustine—melanoma	0.00032	0.00252	CcSEcCtD
Atazanavir—Connective tissue disorder—Carmustine—melanoma	0.00032	0.00251	CcSEcCtD
Atazanavir—Dermatitis bullous—Docetaxel—melanoma	0.000316	0.00248	CcSEcCtD
Atazanavir—Hepatitis—Temozolomide—melanoma	0.000314	0.00247	CcSEcCtD
Atazanavir—Asthenia—Vemurafenib—melanoma	0.000314	0.00246	CcSEcCtD
Atazanavir—Hallucination—Temozolomide—melanoma	0.000313	0.00246	CcSEcCtD
Atazanavir—Hypoaesthesia—Temozolomide—melanoma	0.000313	0.00246	CcSEcCtD
Atazanavir—Urinary tract disorder—Temozolomide—melanoma	0.00031	0.00244	CcSEcCtD
Atazanavir—Oedema peripheral—Temozolomide—melanoma	0.00031	0.00243	CcSEcCtD
Atazanavir—Pruritus—Vemurafenib—melanoma	0.000309	0.00243	CcSEcCtD
Atazanavir—Connective tissue disorder—Temozolomide—melanoma	0.000309	0.00243	CcSEcCtD
Atazanavir—Urethral disorder—Temozolomide—melanoma	0.000308	0.00242	CcSEcCtD
Atazanavir—Alopecia—Dactinomycin—melanoma	0.000307	0.00241	CcSEcCtD
Atazanavir—Eye disorder—Carmustine—melanoma	0.000304	0.00239	CcSEcCtD
Atazanavir—Pain in extremity—Docetaxel—melanoma	0.000302	0.00237	CcSEcCtD
Atazanavir—Ill-defined disorder—Bleomycin—melanoma	0.000301	0.00237	CcSEcCtD
Atazanavir—Diarrhoea—Vemurafenib—melanoma	0.000299	0.00235	CcSEcCtD
Atazanavir—Erythema multiforme—Temozolomide—melanoma	0.000297	0.00234	CcSEcCtD
Atazanavir—Eye disorder—Temozolomide—melanoma	0.000294	0.00231	CcSEcCtD
Atazanavir—Tinnitus—Temozolomide—melanoma	0.000293	0.0023	CcSEcCtD
Atazanavir—Malaise—Bleomycin—melanoma	0.000293	0.0023	CcSEcCtD
Atazanavir—Cardiac disorder—Temozolomide—melanoma	0.000292	0.00229	CcSEcCtD
Atazanavir—Saquinavir—ALB—melanoma	0.000291	0.212	CrCbGaD
Atazanavir—Dizziness—Vemurafenib—melanoma	0.000289	0.00227	CcSEcCtD
Atazanavir—Alopecia—Carmustine—melanoma	0.000287	0.00226	CcSEcCtD
Atazanavir—Angiopathy—Temozolomide—melanoma	0.000285	0.00224	CcSEcCtD
Atazanavir—Mental disorder—Carmustine—melanoma	0.000285	0.00224	CcSEcCtD
Atazanavir—Immune system disorder—Temozolomide—melanoma	0.000284	0.00223	CcSEcCtD
Atazanavir—Mediastinal disorder—Temozolomide—melanoma	0.000283	0.00223	CcSEcCtD
Atazanavir—Malnutrition—Carmustine—melanoma	0.000283	0.00223	CcSEcCtD
Atazanavir—Cough—Bleomycin—melanoma	0.000283	0.00222	CcSEcCtD
Atazanavir—Dehydration—Docetaxel—melanoma	0.000281	0.00221	CcSEcCtD
Atazanavir—Ill-defined disorder—Dactinomycin—melanoma	0.000281	0.00221	CcSEcCtD
Atazanavir—Vomiting—Vemurafenib—melanoma	0.000278	0.00218	CcSEcCtD
Atazanavir—Alopecia—Temozolomide—melanoma	0.000278	0.00218	CcSEcCtD
Atazanavir—Saquinavir—ABCB1—melanoma	0.000277	0.203	CrCbGaD
Atazanavir—Dry skin—Docetaxel—melanoma	0.000277	0.00218	CcSEcCtD
Atazanavir—Chest pain—Bleomycin—melanoma	0.000276	0.00217	CcSEcCtD
Atazanavir—Myalgia—Bleomycin—melanoma	0.000276	0.00217	CcSEcCtD
Atazanavir—Rash—Vemurafenib—melanoma	0.000276	0.00217	CcSEcCtD
Atazanavir—Mental disorder—Temozolomide—melanoma	0.000275	0.00216	CcSEcCtD
Atazanavir—Dermatitis—Vemurafenib—melanoma	0.000275	0.00216	CcSEcCtD
Atazanavir—Back pain—Carmustine—melanoma	0.000274	0.00215	CcSEcCtD
Atazanavir—Headache—Vemurafenib—melanoma	0.000274	0.00215	CcSEcCtD
Atazanavir—Malnutrition—Temozolomide—melanoma	0.000274	0.00215	CcSEcCtD
Atazanavir—Breast disorder—Docetaxel—melanoma	0.000273	0.00215	CcSEcCtD
Atazanavir—Discomfort—Bleomycin—melanoma	0.000273	0.00214	CcSEcCtD
Atazanavir—Malaise—Dactinomycin—melanoma	0.000273	0.00214	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000272	0.00214	CcSEcCtD
Atazanavir—Nasopharyngitis—Docetaxel—melanoma	0.00027	0.00212	CcSEcCtD
Atazanavir—Dysgeusia—Temozolomide—melanoma	0.000268	0.00211	CcSEcCtD
Atazanavir—Confusional state—Bleomycin—melanoma	0.000267	0.0021	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Docetaxel—melanoma	0.000266	0.00209	CcSEcCtD
Atazanavir—Oedema—Bleomycin—melanoma	0.000265	0.00208	CcSEcCtD
Atazanavir—Back pain—Temozolomide—melanoma	0.000265	0.00208	CcSEcCtD
Atazanavir—Infection—Bleomycin—melanoma	0.000263	0.00207	CcSEcCtD
Atazanavir—Agitation—Carmustine—melanoma	0.00026	0.00204	CcSEcCtD
Atazanavir—Nausea—Vemurafenib—melanoma	0.00026	0.00204	CcSEcCtD
Atazanavir—Myalgia—Dactinomycin—melanoma	0.000258	0.00202	CcSEcCtD
Atazanavir—Discomfort—Dactinomycin—melanoma	0.000254	0.002	CcSEcCtD
Atazanavir—Ill-defined disorder—Temozolomide—melanoma	0.000254	0.002	CcSEcCtD
Atazanavir—Anorexia—Bleomycin—melanoma	0.000252	0.00198	CcSEcCtD
Atazanavir—Agitation—Temozolomide—melanoma	0.000251	0.00198	CcSEcCtD
Atazanavir—Angioedema—Temozolomide—melanoma	0.00025	0.00196	CcSEcCtD
Atazanavir—Oedema—Dactinomycin—melanoma	0.000247	0.00194	CcSEcCtD
Atazanavir—Malaise—Temozolomide—melanoma	0.000247	0.00194	CcSEcCtD
Atazanavir—Convulsion—Carmustine—melanoma	0.000245	0.00193	CcSEcCtD
Atazanavir—Infection—Dactinomycin—melanoma	0.000245	0.00193	CcSEcCtD
Atazanavir—Hypertension—Carmustine—melanoma	0.000244	0.00192	CcSEcCtD
Atazanavir—Neutropenia—Docetaxel—melanoma	0.000244	0.00192	CcSEcCtD
Atazanavir—Palpitations—Temozolomide—melanoma	0.000242	0.0019	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Bleomycin—melanoma	0.000241	0.0019	CcSEcCtD
Atazanavir—Chest pain—Carmustine—melanoma	0.000241	0.00189	CcSEcCtD
Atazanavir—Myalgia—Carmustine—melanoma	0.000241	0.00189	CcSEcCtD
Atazanavir—Anxiety—Carmustine—melanoma	0.00024	0.00189	CcSEcCtD
Atazanavir—Cough—Temozolomide—melanoma	0.000239	0.00188	CcSEcCtD
Atazanavir—Weight increased—Docetaxel—melanoma	0.000238	0.00187	CcSEcCtD
Atazanavir—Convulsion—Temozolomide—melanoma	0.000237	0.00186	CcSEcCtD
Atazanavir—Weight decreased—Docetaxel—melanoma	0.000236	0.00186	CcSEcCtD
Atazanavir—Hypertension—Temozolomide—melanoma	0.000236	0.00186	CcSEcCtD
Atazanavir—Dyspnoea—Bleomycin—melanoma	0.000236	0.00185	CcSEcCtD
Atazanavir—Anorexia—Dactinomycin—melanoma	0.000235	0.00185	CcSEcCtD
Atazanavir—Confusional state—Carmustine—melanoma	0.000233	0.00183	CcSEcCtD
Atazanavir—Myalgia—Temozolomide—melanoma	0.000233	0.00183	CcSEcCtD
Atazanavir—Arthralgia—Temozolomide—melanoma	0.000233	0.00183	CcSEcCtD
Atazanavir—Anxiety—Temozolomide—melanoma	0.000232	0.00182	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000231	0.00182	CcSEcCtD
Atazanavir—Oedema—Carmustine—melanoma	0.000231	0.00182	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000231	0.00181	CcSEcCtD
Atazanavir—Discomfort—Temozolomide—melanoma	0.00023	0.00181	CcSEcCtD
Atazanavir—Decreased appetite—Bleomycin—melanoma	0.00023	0.00181	CcSEcCtD
Atazanavir—Infection—Carmustine—melanoma	0.00023	0.0018	CcSEcCtD
Atazanavir—Renal failure—Docetaxel—melanoma	0.000229	0.0018	CcSEcCtD
Atazanavir—Neuropathy peripheral—Docetaxel—melanoma	0.000228	0.00179	CcSEcCtD
Atazanavir—Dry mouth—Temozolomide—melanoma	0.000228	0.00179	CcSEcCtD
Atazanavir—Jaundice—Docetaxel—melanoma	0.000227	0.00178	CcSEcCtD
Atazanavir—Stomatitis—Docetaxel—melanoma	0.000227	0.00178	CcSEcCtD
Atazanavir—Pain—Bleomycin—melanoma	0.000226	0.00178	CcSEcCtD
Atazanavir—Confusional state—Temozolomide—melanoma	0.000225	0.00177	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000225	0.00177	CcSEcCtD
Atazanavir—Oedema—Temozolomide—melanoma	0.000223	0.00176	CcSEcCtD
Atazanavir—Infection—Temozolomide—melanoma	0.000222	0.00174	CcSEcCtD
Atazanavir—Anorexia—Carmustine—melanoma	0.00022	0.00173	CcSEcCtD
Atazanavir—Hepatobiliary disease—Docetaxel—melanoma	0.00022	0.00173	CcSEcCtD
Atazanavir—Nervous system disorder—Temozolomide—melanoma	0.000219	0.00172	CcSEcCtD
Atazanavir—Feeling abnormal—Bleomycin—melanoma	0.000218	0.00171	CcSEcCtD
Atazanavir—Skin disorder—Temozolomide—melanoma	0.000217	0.0017	CcSEcCtD
Atazanavir—Hyperhidrosis—Temozolomide—melanoma	0.000216	0.0017	CcSEcCtD
Atazanavir—Decreased appetite—Dactinomycin—melanoma	0.000215	0.00169	CcSEcCtD
Atazanavir—Fatigue—Dactinomycin—melanoma	0.000213	0.00167	CcSEcCtD
Atazanavir—Anorexia—Temozolomide—melanoma	0.000213	0.00167	CcSEcCtD
Atazanavir—Pain—Dactinomycin—melanoma	0.000211	0.00166	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Carmustine—melanoma	0.000211	0.00165	CcSEcCtD
Atazanavir—Urticaria—Bleomycin—melanoma	0.00021	0.00165	CcSEcCtD
Atazanavir—Body temperature increased—Bleomycin—melanoma	0.000209	0.00164	CcSEcCtD
Atazanavir—Hepatitis—Docetaxel—melanoma	0.000209	0.00164	CcSEcCtD
Atazanavir—Insomnia—Carmustine—melanoma	0.000209	0.00164	CcSEcCtD
Atazanavir—Hypoaesthesia—Docetaxel—melanoma	0.000208	0.00163	CcSEcCtD
Atazanavir—Urinary tract disorder—Docetaxel—melanoma	0.000206	0.00162	CcSEcCtD
Atazanavir—Dyspnoea—Carmustine—melanoma	0.000206	0.00162	CcSEcCtD
Atazanavir—Oedema peripheral—Docetaxel—melanoma	0.000206	0.00162	CcSEcCtD
Atazanavir—Somnolence—Carmustine—melanoma	0.000205	0.00161	CcSEcCtD
Atazanavir—Connective tissue disorder—Docetaxel—melanoma	0.000205	0.00161	CcSEcCtD
Atazanavir—Urethral disorder—Docetaxel—melanoma	0.000205	0.00161	CcSEcCtD
Atazanavir—Feeling abnormal—Dactinomycin—melanoma	0.000203	0.0016	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Temozolomide—melanoma	0.000203	0.0016	CcSEcCtD
Atazanavir—Insomnia—Temozolomide—melanoma	0.000202	0.00159	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dactinomycin—melanoma	0.000202	0.00159	CcSEcCtD
Atazanavir—Decreased appetite—Carmustine—melanoma	0.000201	0.00158	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Carmustine—melanoma	0.0002	0.00157	CcSEcCtD
Atazanavir—Dyspnoea—Temozolomide—melanoma	0.000199	0.00156	CcSEcCtD
Atazanavir—Somnolence—Temozolomide—melanoma	0.000199	0.00156	CcSEcCtD
Atazanavir—Erythema multiforme—Docetaxel—melanoma	0.000198	0.00155	CcSEcCtD
Atazanavir—Constipation—Carmustine—melanoma	0.000198	0.00155	CcSEcCtD
Atazanavir—Pain—Carmustine—melanoma	0.000198	0.00155	CcSEcCtD
Atazanavir—Dyspepsia—Temozolomide—melanoma	0.000197	0.00154	CcSEcCtD
Atazanavir—Eye disorder—Docetaxel—melanoma	0.000195	0.00154	CcSEcCtD
Atazanavir—Body temperature increased—Dactinomycin—melanoma	0.000195	0.00153	CcSEcCtD
Atazanavir—Abdominal pain—Dactinomycin—melanoma	0.000195	0.00153	CcSEcCtD
Atazanavir—Hypersensitivity—Bleomycin—melanoma	0.000195	0.00153	CcSEcCtD
Atazanavir—Decreased appetite—Temozolomide—melanoma	0.000194	0.00153	CcSEcCtD
Atazanavir—Cardiac disorder—Docetaxel—melanoma	0.000194	0.00152	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Temozolomide—melanoma	0.000193	0.00152	CcSEcCtD
Atazanavir—Fatigue—Temozolomide—melanoma	0.000193	0.00151	CcSEcCtD
Atazanavir—Constipation—Temozolomide—melanoma	0.000191	0.0015	CcSEcCtD
Atazanavir—Pain—Temozolomide—melanoma	0.000191	0.0015	CcSEcCtD
Atazanavir—Feeling abnormal—Carmustine—melanoma	0.00019	0.0015	CcSEcCtD
Atazanavir—Asthenia—Bleomycin—melanoma	0.00019	0.00149	CcSEcCtD
Atazanavir—Angiopathy—Docetaxel—melanoma	0.00019	0.00149	CcSEcCtD
Atazanavir—Gastrointestinal pain—Carmustine—melanoma	0.000189	0.00149	CcSEcCtD
Atazanavir—Immune system disorder—Docetaxel—melanoma	0.000189	0.00148	CcSEcCtD
Atazanavir—Mediastinal disorder—Docetaxel—melanoma	0.000188	0.00148	CcSEcCtD
Atazanavir—Pruritus—Bleomycin—melanoma	0.000187	0.00147	CcSEcCtD
Atazanavir—Alopecia—Docetaxel—melanoma	0.000185	0.00145	CcSEcCtD
Atazanavir—Feeling abnormal—Temozolomide—melanoma	0.000184	0.00145	CcSEcCtD
Atazanavir—Mental disorder—Docetaxel—melanoma	0.000183	0.00144	CcSEcCtD
Atazanavir—Abdominal pain—Carmustine—melanoma	0.000183	0.00144	CcSEcCtD
Atazanavir—Body temperature increased—Carmustine—melanoma	0.000183	0.00144	CcSEcCtD
Atazanavir—Gastrointestinal pain—Temozolomide—melanoma	0.000183	0.00144	CcSEcCtD
Atazanavir—Malnutrition—Docetaxel—melanoma	0.000182	0.00143	CcSEcCtD
Atazanavir—Hypersensitivity—Dactinomycin—melanoma	0.000182	0.00143	CcSEcCtD
Atazanavir—Dysgeusia—Docetaxel—melanoma	0.000178	0.0014	CcSEcCtD
Atazanavir—Urticaria—Temozolomide—melanoma	0.000177	0.00139	CcSEcCtD
Atazanavir—Asthenia—Dactinomycin—melanoma	0.000177	0.00139	CcSEcCtD
Atazanavir—Body temperature increased—Temozolomide—melanoma	0.000177	0.00139	CcSEcCtD
Atazanavir—Abdominal pain—Temozolomide—melanoma	0.000177	0.00139	CcSEcCtD
Atazanavir—Back pain—Docetaxel—melanoma	0.000176	0.00138	CcSEcCtD
Atazanavir—Hypersensitivity—Carmustine—melanoma	0.00017	0.00134	CcSEcCtD
Atazanavir—Diarrhoea—Dactinomycin—melanoma	0.000169	0.00133	CcSEcCtD
Atazanavir—Vomiting—Bleomycin—melanoma	0.000168	0.00132	CcSEcCtD
Atazanavir—Rash—Bleomycin—melanoma	0.000167	0.00131	CcSEcCtD
Atazanavir—Dermatitis—Bleomycin—melanoma	0.000167	0.00131	CcSEcCtD
Atazanavir—Asthenia—Carmustine—melanoma	0.000166	0.0013	CcSEcCtD
Atazanavir—Hypersensitivity—Temozolomide—melanoma	0.000165	0.00129	CcSEcCtD
Atazanavir—Syncope—Docetaxel—melanoma	0.000163	0.00128	CcSEcCtD
Atazanavir—Palpitations—Docetaxel—melanoma	0.000161	0.00126	CcSEcCtD
Atazanavir—Asthenia—Temozolomide—melanoma	0.00016	0.00126	CcSEcCtD
Atazanavir—Loss of consciousness—Docetaxel—melanoma	0.00016	0.00126	CcSEcCtD
Atazanavir—Cough—Docetaxel—melanoma	0.000159	0.00125	CcSEcCtD
Atazanavir—Diarrhoea—Carmustine—melanoma	0.000158	0.00124	CcSEcCtD
Atazanavir—Pruritus—Temozolomide—melanoma	0.000158	0.00124	CcSEcCtD
Atazanavir—Convulsion—Docetaxel—melanoma	0.000158	0.00124	CcSEcCtD
Atazanavir—Nausea—Bleomycin—melanoma	0.000157	0.00124	CcSEcCtD
Atazanavir—Hypertension—Docetaxel—melanoma	0.000157	0.00123	CcSEcCtD
Atazanavir—Vomiting—Dactinomycin—melanoma	0.000157	0.00123	CcSEcCtD
Atazanavir—Rash—Dactinomycin—melanoma	0.000156	0.00122	CcSEcCtD
Atazanavir—Chest pain—Docetaxel—melanoma	0.000155	0.00122	CcSEcCtD
Atazanavir—Arthralgia—Docetaxel—melanoma	0.000155	0.00122	CcSEcCtD
Atazanavir—Myalgia—Docetaxel—melanoma	0.000155	0.00122	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000154	0.00121	CcSEcCtD
Atazanavir—Dizziness—Carmustine—melanoma	0.000153	0.0012	CcSEcCtD
Atazanavir—Diarrhoea—Temozolomide—melanoma	0.000153	0.0012	CcSEcCtD
Atazanavir—Dry mouth—Docetaxel—melanoma	0.000152	0.00119	CcSEcCtD
Atazanavir—Confusional state—Docetaxel—melanoma	0.00015	0.00118	CcSEcCtD
Atazanavir—Oedema—Docetaxel—melanoma	0.000149	0.00117	CcSEcCtD
Atazanavir—Dizziness—Temozolomide—melanoma	0.000148	0.00116	CcSEcCtD
Atazanavir—Infection—Docetaxel—melanoma	0.000148	0.00116	CcSEcCtD
Atazanavir—Vomiting—Carmustine—melanoma	0.000147	0.00115	CcSEcCtD
Atazanavir—Nausea—Dactinomycin—melanoma	0.000147	0.00115	CcSEcCtD
Atazanavir—Shock—Docetaxel—melanoma	0.000146	0.00115	CcSEcCtD
Atazanavir—Rash—Carmustine—melanoma	0.000146	0.00115	CcSEcCtD
Atazanavir—Nervous system disorder—Docetaxel—melanoma	0.000146	0.00114	CcSEcCtD
Atazanavir—Dermatitis—Carmustine—melanoma	0.000146	0.00114	CcSEcCtD
Atazanavir—Headache—Carmustine—melanoma	0.000145	0.00114	CcSEcCtD
Atazanavir—Skin disorder—Docetaxel—melanoma	0.000144	0.00113	CcSEcCtD
Atazanavir—Vomiting—Temozolomide—melanoma	0.000142	0.00112	CcSEcCtD
Atazanavir—Anorexia—Docetaxel—melanoma	0.000142	0.00111	CcSEcCtD
Atazanavir—Rash—Temozolomide—melanoma	0.000141	0.00111	CcSEcCtD
Atazanavir—Dermatitis—Temozolomide—melanoma	0.000141	0.00111	CcSEcCtD
Atazanavir—Headache—Temozolomide—melanoma	0.00014	0.0011	CcSEcCtD
Atazanavir—Nausea—Carmustine—melanoma	0.000137	0.00108	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Docetaxel—melanoma	0.000135	0.00106	CcSEcCtD
Atazanavir—Insomnia—Docetaxel—melanoma	0.000134	0.00106	CcSEcCtD
Atazanavir—Nausea—Temozolomide—melanoma	0.000133	0.00104	CcSEcCtD
Atazanavir—Dyspnoea—Docetaxel—melanoma	0.000132	0.00104	CcSEcCtD
Atazanavir—Somnolence—Docetaxel—melanoma	0.000132	0.00104	CcSEcCtD
Atazanavir—Dyspepsia—Docetaxel—melanoma	0.000131	0.00103	CcSEcCtD
Atazanavir—Decreased appetite—Docetaxel—melanoma	0.000129	0.00101	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Docetaxel—melanoma	0.000128	0.00101	CcSEcCtD
Atazanavir—Fatigue—Docetaxel—melanoma	0.000128	0.00101	CcSEcCtD
Atazanavir—Constipation—Docetaxel—melanoma	0.000127	0.000998	CcSEcCtD
Atazanavir—Pain—Docetaxel—melanoma	0.000127	0.000998	CcSEcCtD
Atazanavir—Feeling abnormal—Docetaxel—melanoma	0.000122	0.000962	CcSEcCtD
Atazanavir—Gastrointestinal pain—Docetaxel—melanoma	0.000121	0.000954	CcSEcCtD
Atazanavir—Abdominal pain—Docetaxel—melanoma	0.000117	0.000923	CcSEcCtD
Atazanavir—Body temperature increased—Docetaxel—melanoma	0.000117	0.000923	CcSEcCtD
Atazanavir—Hypersensitivity—Docetaxel—melanoma	0.000109	0.00086	CcSEcCtD
Atazanavir—Asthenia—Docetaxel—melanoma	0.000107	0.000837	CcSEcCtD
Atazanavir—Pruritus—Docetaxel—melanoma	0.000105	0.000826	CcSEcCtD
Atazanavir—Diarrhoea—Docetaxel—melanoma	0.000102	0.000799	CcSEcCtD
Atazanavir—Dizziness—Docetaxel—melanoma	9.82e-05	0.000772	CcSEcCtD
Atazanavir—Vomiting—Docetaxel—melanoma	9.44e-05	0.000742	CcSEcCtD
Atazanavir—Rash—Docetaxel—melanoma	9.36e-05	0.000736	CcSEcCtD
Atazanavir—Dermatitis—Docetaxel—melanoma	9.35e-05	0.000735	CcSEcCtD
Atazanavir—Headache—Docetaxel—melanoma	9.3e-05	0.000731	CcSEcCtD
Atazanavir—Nausea—Docetaxel—melanoma	8.82e-05	0.000693	CcSEcCtD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.42e-05	0.000905	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GNA11—melanoma	1.4e-05	0.00089	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—UGT2B10—melanoma	1.39e-05	0.000889	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—TNF—melanoma	1.39e-05	0.000885	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HS3ST5—melanoma	1.39e-05	0.000884	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PLA2G6—melanoma	1.38e-05	0.000879	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.38e-05	0.000877	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—ALB—melanoma	1.37e-05	0.000873	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—FASN—melanoma	1.37e-05	0.000871	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SLC5A5—melanoma	1.34e-05	0.000857	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.34e-05	0.000852	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1.32e-05	0.000842	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GNAQ—melanoma	1.3e-05	0.000828	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CD44—melanoma	1.3e-05	0.000828	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HS3ST5—melanoma	1.3e-05	0.000826	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.27e-05	0.00081	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.26e-05	0.000803	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP1B1—melanoma	1.24e-05	0.000793	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	1.24e-05	0.000793	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—VCAN—melanoma	1.24e-05	0.00079	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	1.22e-05	0.00078	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.19e-05	0.000761	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.18e-05	0.000754	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GAB2—melanoma	1.18e-05	0.000751	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.17e-05	0.000748	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FASN—melanoma	1.15e-05	0.000735	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.13e-05	0.000722	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.12e-05	0.000717	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FOXO4—melanoma	1.11e-05	0.000707	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HDAC2—melanoma	1.11e-05	0.000707	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CXCR4—melanoma	1.11e-05	0.000707	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.1e-05	0.0007	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD44—melanoma	1.1e-05	0.000699	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.07e-05	0.000681	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.05e-05	0.000671	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLCB4—melanoma	1.05e-05	0.00067	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP17A1—melanoma	1.05e-05	0.000666	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.04e-05	0.000665	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.04e-05	0.000661	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.03e-05	0.000657	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ABCB1—melanoma	1.03e-05	0.000653	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.02e-05	0.000649	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.01e-05	0.000647	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT3—melanoma	1.01e-05	0.000645	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ACER3—melanoma	1.01e-05	0.000641	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIP4K2A—melanoma	9.89e-06	0.00063	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC6A11—melanoma	9.89e-06	0.00063	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GNA11—melanoma	9.87e-06	0.000629	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLCB4—melanoma	9.82e-06	0.000626	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—ALB—melanoma	9.68e-06	0.000617	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—FASN—melanoma	9.66e-06	0.000616	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	9.65e-06	0.000615	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	9.64e-06	0.000615	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTAP—melanoma	9.62e-06	0.000613	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	9.61e-06	0.000613	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC5A5—melanoma	9.5e-06	0.000606	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PRKCA—melanoma	9.43e-06	0.000601	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	9.42e-06	0.0006	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ERCC2—melanoma	9.36e-06	0.000596	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIP4K2A—melanoma	9.24e-06	0.000589	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC6A11—melanoma	9.24e-06	0.000589	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UGT2B10—melanoma	9.2e-06	0.000586	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GNAQ—melanoma	9.18e-06	0.000585	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CD44—melanoma	9.18e-06	0.000585	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	9.17e-06	0.000584	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	9.08e-06	0.000579	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.99e-06	0.000573	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTAP—melanoma	8.99e-06	0.000573	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB4—melanoma	8.93e-06	0.000569	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.91e-06	0.000568	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	8.87e-06	0.000565	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN2B—melanoma	8.86e-06	0.000565	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	8.85e-06	0.000564	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	8.81e-06	0.000561	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP1B1—melanoma	8.8e-06	0.000561	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	8.78e-06	0.00056	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PHGDH—melanoma	8.57e-06	0.000546	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LUM—melanoma	8.57e-06	0.000546	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD86—melanoma	8.57e-06	0.000546	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HS3ST5—melanoma	8.55e-06	0.000545	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HPSE—melanoma	8.41e-06	0.000536	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF1—melanoma	8.31e-06	0.000529	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CUBN—melanoma	8.25e-06	0.000526	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PDGFRA—melanoma	8.04e-06	0.000513	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LUM—melanoma	8.01e-06	0.00051	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PHGDH—melanoma	8.01e-06	0.00051	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	7.99e-06	0.000509	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SDHD—melanoma	7.97e-06	0.000508	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CSPG4—melanoma	7.97e-06	0.000508	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BSG—melanoma	7.97e-06	0.000508	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PRKCA—melanoma	7.96e-06	0.000508	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERCC2—melanoma	7.9e-06	0.000503	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HPSE—melanoma	7.85e-06	0.000501	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAP2K2—melanoma	7.79e-06	0.000496	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.77e-06	0.000495	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.75e-06	0.000494	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPAM—melanoma	7.72e-06	0.000492	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CUBN—melanoma	7.71e-06	0.000491	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	7.56e-06	0.000482	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SDHD—melanoma	7.45e-06	0.000475	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BSG—melanoma	7.45e-06	0.000475	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CSPG4—melanoma	7.45e-06	0.000475	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TERT—melanoma	7.4e-06	0.000472	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HLA-A—melanoma	7.4e-06	0.000472	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CG—melanoma	7.39e-06	0.000471	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RAC1—melanoma	7.38e-06	0.000471	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	7.35e-06	0.000469	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCB1—melanoma	7.25e-06	0.000462	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPAM—melanoma	7.21e-06	0.00046	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	7.19e-06	0.000459	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	7.19e-06	0.000458	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARG—melanoma	7.13e-06	0.000455	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIF1A—melanoma	7.08e-06	0.000451	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	6.85e-06	0.000437	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	6.79e-06	0.000433	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PRKCA—melanoma	6.67e-06	0.000425	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ERCC2—melanoma	6.61e-06	0.000422	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLA2G6—melanoma	6.56e-06	0.000418	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CD—melanoma	6.5e-06	0.000414	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLCB4—melanoma	6.48e-06	0.000413	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS2—melanoma	6.44e-06	0.000411	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—melanoma	6.41e-06	0.000409	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOTCH1—melanoma	6.38e-06	0.000407	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD80—melanoma	6.25e-06	0.000398	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.24e-06	0.000398	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APC—melanoma	6.24e-06	0.000398	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KIT—melanoma	6.24e-06	0.000398	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGF—melanoma	6.17e-06	0.000393	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLA2G6—melanoma	6.13e-06	0.000391	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC6A11—melanoma	6.09e-06	0.000388	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIP4K2A—melanoma	6.09e-06	0.000388	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.04e-06	0.000385	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTAP—melanoma	5.93e-06	0.000378	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—VCAN—melanoma	5.9e-06	0.000376	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BRAF—melanoma	5.86e-06	0.000374	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CB—melanoma	5.66e-06	0.000361	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—melanoma	5.61e-06	0.000358	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAP2K1—melanoma	5.52e-06	0.000352	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—VCAN—melanoma	5.51e-06	0.000351	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CD—melanoma	5.48e-06	0.00035	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.48e-06	0.000349	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PHGDH—melanoma	5.28e-06	0.000337	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LUM—melanoma	5.28e-06	0.000337	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF2—melanoma	5.25e-06	0.000335	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CG—melanoma	5.22e-06	0.000333	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.21e-06	0.000332	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HPSE—melanoma	5.18e-06	0.00033	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.1e-06	0.000325	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CUBN—melanoma	5.08e-06	0.000324	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARG—melanoma	5.04e-06	0.000321	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.03e-06	0.000321	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP17A1—melanoma	4.97e-06	0.000317	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MDM2—melanoma	4.91e-06	0.000313	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SDHD—melanoma	4.91e-06	0.000313	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CSPG4—melanoma	4.91e-06	0.000313	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BSG—melanoma	4.91e-06	0.000313	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTEN—melanoma	4.89e-06	0.000312	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB2—melanoma	4.84e-06	0.000309	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CB—melanoma	4.78e-06	0.000305	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD4—melanoma	4.77e-06	0.000304	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPAM—melanoma	4.76e-06	0.000303	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—melanoma	4.74e-06	0.000302	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GNA11—melanoma	4.7e-06	0.000299	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP17A1—melanoma	4.65e-06	0.000296	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.6e-06	0.000294	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—FASN—melanoma	4.6e-06	0.000293	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CD—melanoma	4.59e-06	0.000293	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.58e-06	0.000292	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—melanoma	4.53e-06	0.000289	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.52e-06	0.000288	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC5A5—melanoma	4.52e-06	0.000288	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1B—melanoma	4.49e-06	0.000286	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GNA11—melanoma	4.39e-06	0.00028	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GNAQ—melanoma	4.37e-06	0.000278	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CD44—melanoma	4.37e-06	0.000278	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—FASN—melanoma	4.29e-06	0.000274	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CTNNB1—melanoma	4.24e-06	0.00027	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC5A5—melanoma	4.22e-06	0.000269	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1B1—melanoma	4.19e-06	0.000267	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1A—melanoma	4.14e-06	0.000264	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTEN—melanoma	4.13e-06	0.000263	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CD44—melanoma	4.08e-06	0.00026	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GNAQ—melanoma	4.08e-06	0.00026	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLA2G6—melanoma	4.04e-06	0.000258	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CB—melanoma	4e-06	0.000255	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.99e-06	0.000255	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—melanoma	3.97e-06	0.000253	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.96e-06	0.000252	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1B1—melanoma	3.91e-06	0.000249	CbGpPWpGaD
Atazanavir—ABCC1—Disease—STAT3—melanoma	3.69e-06	0.000235	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NRAS—melanoma	3.68e-06	0.000235	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—VCAN—melanoma	3.63e-06	0.000232	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK3—melanoma	3.53e-06	0.000225	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTEN—melanoma	3.46e-06	0.00022	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.45e-06	0.00022	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—melanoma	3.45e-06	0.00022	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—melanoma	3.43e-06	0.000219	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK1—melanoma	3.36e-06	0.000214	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGFR—melanoma	3.36e-06	0.000214	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—melanoma	3.22e-06	0.000205	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PRKCA—melanoma	3.17e-06	0.000202	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KRAS—melanoma	3.17e-06	0.000202	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ERCC2—melanoma	3.15e-06	0.000201	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP17A1—melanoma	3.06e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PRKCA—melanoma	2.96e-06	0.000189	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ERCC2—melanoma	2.94e-06	0.000187	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—melanoma	2.91e-06	0.000186	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GNA11—melanoma	2.89e-06	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FASN—melanoma	2.83e-06	0.000181	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—melanoma	2.82e-06	0.00018	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC5A5—melanoma	2.79e-06	0.000178	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HRAS—melanoma	2.7e-06	0.000172	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GNAQ—melanoma	2.69e-06	0.000171	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CD44—melanoma	2.69e-06	0.000171	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—melanoma	2.58e-06	0.000164	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1B1—melanoma	2.58e-06	0.000164	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CG—melanoma	2.49e-06	0.000158	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—melanoma	2.44e-06	0.000156	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.44e-06	0.000155	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARG—melanoma	2.4e-06	0.000153	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—melanoma	2.38e-06	0.000152	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CG—melanoma	2.32e-06	0.000148	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARG—melanoma	2.24e-06	0.000143	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CD—melanoma	2.18e-06	0.000139	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—melanoma	2.16e-06	0.000137	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—melanoma	2.12e-06	0.000135	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CD—melanoma	2.04e-06	0.00013	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—melanoma	2.01e-06	0.000128	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—melanoma	1.99e-06	0.000127	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PRKCA—melanoma	1.95e-06	0.000125	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ERCC2—melanoma	1.94e-06	0.000124	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CB—melanoma	1.9e-06	0.000121	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—melanoma	1.89e-06	0.00012	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CB—melanoma	1.78e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—melanoma	1.76e-06	0.000112	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTEN—melanoma	1.65e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTEN—melanoma	1.54e-06	9.8e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CG—melanoma	1.53e-06	9.76e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARG—melanoma	1.48e-06	9.42e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CD—melanoma	1.35e-06	8.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—melanoma	1.33e-06	8.47e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CB—melanoma	1.17e-06	7.48e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—melanoma	1.16e-06	7.41e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—melanoma	1.16e-06	7.4e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—melanoma	1.08e-06	6.91e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTEN—melanoma	1.01e-06	6.46e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—melanoma	9.48e-07	6.04e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—melanoma	8.86e-07	5.65e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—melanoma	7.15e-07	4.56e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—melanoma	5.84e-07	3.72e-05	CbGpPWpGaD
